Russell Investments Group, Ltd. Travere Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 161,266 shares of TVTX stock, worth $3.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

161,266

Previous 166,057 2.89%

Holding current value

$3.04 Million

Previous $1.36 Million 65.4%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.89 - $15.21 $37,800 - $72,871	-4,791 Reduced 2.89%	161,266 $2.26 Million
Q2 2024 Aug 08, 2024	SELL	$5.26 - $8.28 $97,657 - $153,726	-18,566 Reduced 10.06%	166,057 $1.36 Million
Q1 2024 May 08, 2024	BUY	$7.18 - $9.82 $585,966 - $801,420	81,611 Added 79.22%	184,623 $1.42 Million
Q4 2023 Feb 05, 2024	BUY	$5.44 - $9.5 $29,914 - $52,240	5,499 Added 5.64%	103,012 $926,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $5,890 - $13,299	771 Added 0.8%	97,513 $871,000
Q2 2023 Aug 10, 2023	BUY	$15.3 - $22.61 $11,949 - $17,658	781 Added 0.81%	96,742 $1.49 Million
Q1 2023 May 09, 2023	BUY	$17.82 - $22.89 $761,911 - $978,684	42,756 Added 80.36%	95,961 $2.16 Million
Q4 2022 Feb 08, 2023	BUY	$18.47 - $26.14 $410,200 - $580,543	22,209 Added 71.65%	53,205 $1.12 Million
Q3 2022 Nov 04, 2022	SELL	$22.91 - $28.63 $288,207 - $360,165	-12,580 Reduced 28.87%	30,996 $762,000
Q2 2022 Jul 29, 2022	SELL	$20.94 - $30.01 $95,653 - $137,085	-4,568 Reduced 9.49%	43,576 $1.05 Million
Q1 2022 May 05, 2022	SELL	$23.61 - $30.6 $451,824 - $585,592	-19,137 Reduced 28.44%	48,144 $1.24 Million
Q4 2021 Jan 21, 2022	SELL	$24.34 - $31.17 $452,115 - $578,982	-18,575 Reduced 21.64%	67,281 $2.09 Million
Q3 2021 Nov 08, 2021	SELL	$12.98 - $25.03 $191,935 - $370,118	-14,787 Reduced 14.69%	85,856 $2.08 Million
Q2 2021 Aug 04, 2021	SELL	$14.11 - $26.4 $816,009 - $1.53 Million	-57,832 Reduced 36.49%	100,643 $1.47 Million
Q1 2021 May 10, 2021	BUY	$23.37 - $31.77 $3.7 Million - $5.03 Million	158,475 New	158,475 $3.96 Million

Others Institutions Holding TVTX

# of Institutions

194

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.21B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Travere Therapeutics, Inc. Transaction History